Follow
Jinfu Peng
Jinfu Peng
Verified email at uw.edu
Title
Cited by
Cited by
Year
Transcriptional repression of CYP3A4 by increased miR-200a-3p and miR-150-5p promotes steatosis in vitro
Z Huang, M Wang, L Liu, J Peng, C Guo, X Chen, L Huang, J Tan, G Yang
Frontiers in Genetics 10, 428926, 2019
182019
Genotype-guided dosing of warfarin in Chinese adults: a multicenter randomized clinical trial
C Guo, Y Kuang, H Zhou, H Yuan, Q Pei, J Li, W Jiang, CM Ng, X Chen, ...
Circulation: Genomic and Precision Medicine 13 (4), e002602, 2020
162020
Prediction of pregnancy-induced changes in secretory and total renal clearance of drugs transported by organic anion transporters
J Peng, MK Ladumor, JD Unadkat
Drug Metabolism and Disposition 49 (10), 929-937, 2021
132021
Effects of vitamin D on drugs: Response and disposal
J Peng, Y Liu, J Xie, G Yang, Z Huang
Nutrition 74, 110734, 2020
112020
Role of miR-511 in the regulation of OATP1B1 expression by free fatty acid
JF Peng, L Liu, CX Guo, SK Liu, XP Chen, LH Huang, H Xiang, ZJ Huang, ...
Biomolecules & Therapeutics 23 (5), 400, 2015
92015
CRISPR/Cas9-Mediated Whole Genomic Wide Knockout Screening Identifies Specific Genes Associated With PM2.5-Induced Mineral Absorption in Liver Toxicity
J Peng, B Yi, M Wang, J Tan, Z Huang
Frontiers in Bioengineering and Biotechnology 9, 669434, 2021
82021
Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio of P-glycoprotein and/or breast cancer resistance protein substrate drugs using a maternal-fetal …
J Peng, MK Ladumor, JD Unadkat
Drug Metabolism and Disposition 50 (5), 613-623, 2022
62022
Cytochrome P450 2D6* 10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects
Q Pei, J Peng, H Tan, L Yang, X Yang, L Liu, S Liu, H Yuan, G Yang
European journal of drug metabolism and pharmacokinetics 40, 427-433, 2015
42015
Vitamin D deficiency impacts exposure and response of pravastatin in male rats by altering hepatic OATPs
J Peng, G Yang, Z Huang
Frontiers in Pharmacology 13, 841954, 2022
22022
Regulative effects of miR-150 on CYP3A4
L LIU, J PENG, C GUO, X YANG, H LI, G YANG
Chinese Journal of Clinical Pharmacology and Therapeutics 23 (7), 749, 2018
22018
Simple and sensitive LC‐MS/MS‐based assay for the quantification of dimemorfan in human plasma for use in a pharmacokinetic study
H Tan, J Peng, Q Pei, L Yang, J Chen, C Guo, Y Hua, H Yuan, G Yang
Biomedical Chromatography 29 (5), 647-653, 2015
22015
Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio (Kp, uu, fetal) of P-gp and/or BCRP substrate drugs using a maternal-fetal PBPK model
J Peng, MK Ladumor, JD Unadkat
Drug Metabolism and Disposition, 2022
12022
The pharmacokinetic challenge of polymyxin B in critically ill patients with morbid obesity
Y Xie, J Liu, J Peng, Y Li, Y Lin, Q Pei, X Zuo
Journal of global antimicrobial resistance 27, 172-174, 2021
12021
Model-Informed Dose Selection for a Novel Human Immunoglobulin G4 Derived Monoclonal Antibody Targeting Proprotein Convertase Kwashiorkor Type 9: Insights from Population …
J Peng, J Huang, H Tan, Y Kuang, G Yang, Z Huang
ACS Pharmacology & Translational Science 7 (2), 406-420, 2024
2024
CRISPR/Cas9-Mediated Whole Genomic Wide Knockout Screening Identifies Specific Genes Related to Mineral Absorption Involving in PM2. 5 Liver Toxicity
J Peng, B Yi, M Wang, J Tan, Z Huang
2020
Development of traditional Chinese medicine based on material mapping
G YANG, Q PEI, J PENG
Chinese Journal of Clinical Pharmacology and Therapeutics 22 (2), 121, 2017
2017
Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio (𝐊𝐩, 𝐮𝐮, 𝐟𝐞𝐭𝐚𝐥) of P-gp and/or BCRP substrate drugs using a maternal-fetal PBPK model
J Peng, MK Ladumor, JD Unadkat
Prediction of pregnancy-related changes in secretory and total renal clearance of drugs transported by organic anion transporters
J Peng, MK Ladumor, JD Unadkat
The system can't perform the operation now. Try again later.
Articles 1–18